NASDAQ : AMRX

Amneal Pharmaceuticals, Inc. — Key statistics

Healthcare · Drug Manufacturers - Specialty & Generic · United States

Last price 21.51 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 7.49B

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Key statistics

Valuation

MeasureValue
Market Cap7.15B
Enterprise Value9.81B

Dates

MeasureValue
Earnings DateNov 3, 2026
Ex-Dividend Daten/a

Shares

MeasureValue
Current Share Class348.30M
Shares Outstanding348.30M
Shares Change (YoY)+3.48%
Shares Change (QoQ)-0.25%
Owned by Insiders (%)38.19%
Owned by Institutions (%)48.36%
Float215.21M

Ratios

MeasureValue
PE Ratio42.70
Forward PE20.37
PS Ratio2.33
Forward PS2.24
PB Ratio207.99
P/TBV Ration/a
P/FCF Ratio87.51
P/OCF Ratio36.22
PEG Ratio2.37

Evratios

MeasureValue
EV / Earnings63.12
EV / Sales3.19
EV / EBITDA14.41
EV / EBIT20.06
EV / FCF119.52

Financialposition

MeasureValue
Current Ratio2.20
Quick Ratio1.37
Debt / Equity23.87
Debt / EBITDA3.94
Debt / FCF33.59
Interest Coverage2.18

Financialefficiency

MeasureValue
Return on Equity (ROE)613.02%
Return on Assets (ROA)8.60%
Return on Invested Capital (ROIC)18.64%
Return on Capital Employed (ROCE)17.11%
Weighted Average Cost of Capital (WACC)9.70%
Revenue Per Employee$358,339
Profits Per Employee$18,088
Employee Count8,700
Asset Turnover0.87
Inventory Turnover2.92

Taxes

MeasureValue
Income Tax-14.14M
Effective Tax Raten/a

Stockprice

MeasureValue
Beta (5Y)1.22
52-Week Price Change+89.74%
50-Day Moving Average19.17
200-Day Moving Average15.78
Relative Strength Index (RSI)54.52
Average Volume (20 Days)3,572,909

Shortselling

MeasureValue
Short Interest14.07M
Short Previous Month11.28M
Short % of Shares Out4.04%
Short % of Float6.54%
Short Ratio (days to cover)3.80

Incomestatement

MeasureValue
Revenue3.12B
Gross Profit1.24B
Operating Income495.15M
Pretax Income201.18M
Net Income157.36M
EBITDA689.44M
EBIT495.15M
Earnings Per Share (EPS)$0.48

Balancesheet

MeasureValue
Cash & Cash Equivalents131.41M
Total Debt2.79B
Net Cash-2.66B
Net Cash Per Share-$7.64
Equity (Book Value)116.98M
Book Value Per Share0.10
Working Capital1.06B

Cashflow

MeasureValue
Operating Cash Flow200.78M
Capital Expenditures-117.67M
Depreciation & Amortization194.29M
Net Borrowing228.33M
Free Cash Flow83.11M
FCF Per Share$0.24

Margins

MeasureValue
Gross Margin39.81%
Operating Margin15.88%
Pretax Margin6.45%
Profit Margin5.05%
EBITDA Margin22.11%
EBIT Margin15.88%
FCF Margin2.67%

Dividends

MeasureValue
Dividend Per Sharen/a
Dividend Yieldn/a
Dividend Growth (YoY)n/a
Years of Dividend Growthn/a
Payout Ration/a
FCF Payout Ration/a
Buyback Yield-3.48%
Shareholder Yield-3.48%
Earnings Yield2.34%
FCF Yield1.14%

Analystforecasts

MeasureValue
Price Target$23.43
Price Target Difference14.13%
Analyst ConsensusStrong Buy
Analyst Count7
Revenue Growth Forecast (3Y)8.11%
EPS Growth Forecast (3Y)20.60%

Stocksplits

MeasureValue
Last Split Daten/a
Split Typen/a
Split Ration/a

Scores

MeasureValue
Altman Z-Score2.06
Piotroski F-Score7

Fairvalue

MeasureValue
Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside